Posted on

Pretomanid for the treatment of drug-resistant tuberculosis

General Track – Cycle 2 | Drugs

HTA Council Recommendation (as of 08 April 2025)

The HTA Council positively recommends the government financing of Pretomanid for the treatment of drug-resistant tuberculosis (See below for more details)

Relevant Information

  • Dosage Strength: 200 mg
  • Dosage Form: Tablet
  • Status: With Final HTA Council Recommendation
  • Topic Assignment: Internal Assessment
  • Policy Question: Should Pretomanid for the treatment of drug-resistant tuberculosis be funded by the government?
  • Secretary of Health Decision: Approved for inclusion in the Philippine National Formulary

Evidence and Relevant Documents

Assessments Page